Masanori Abe

9.7k total citations
307 papers, 6.3k citations indexed

About

Masanori Abe is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Masanori Abe has authored 307 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Epidemiology, 130 papers in Hepatology and 57 papers in Surgery. Recurrent topics in Masanori Abe's work include Liver Disease Diagnosis and Treatment (132 papers), Liver Diseases and Immunity (46 papers) and Liver Disease and Transplantation (44 papers). Masanori Abe is often cited by papers focused on Liver Disease Diagnosis and Treatment (132 papers), Liver Diseases and Immunity (46 papers) and Liver Disease and Transplantation (44 papers). Masanori Abe collaborates with scholars based in Japan, United States and China. Masanori Abe's co-authors include Yoichi Hiasa, Morikazu Onji, Bunzo Matsuura, Angus W. Thomson, Masashi Hirooka, Teru Kumagi, Tomo Kusunoki, Teruki Miyake, Yoshio Tokumoto and Norio Horiike and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Masanori Abe

293 papers receiving 6.2k citations

Peers

Masanori Abe
Yoichi Hiasa Japan
Mario Pirisi Italy
Parambir S. Dulai United States
Robert J. de Knegt Netherlands
Stephen Ryder United Kingdom
Daniel Q. Huang Singapore
Qin Ning China
Andrew S. Klein United States
Antonio Grieco Italy
Davor Štimac Croatia
Yoichi Hiasa Japan
Masanori Abe
Citations per year, relative to Masanori Abe Masanori Abe (= 1×) peers Yoichi Hiasa

Countries citing papers authored by Masanori Abe

Since Specialization
Citations

This map shows the geographic impact of Masanori Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Abe more than expected).

Fields of papers citing papers by Masanori Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanori Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Abe. The network helps show where Masanori Abe may publish in the future.

Co-authorship network of co-authors of Masanori Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Abe. A scholar is included among the top collaborators of Masanori Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Abe. Masanori Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Atsushi, Kenji Notohara, Maki Tobari, et al.. (2025). A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy. Journal of Gastroenterology. 60(5). 632–640.
2.
Kawamoto, Ryuichi, et al.. (2025). High serum uric acid/creatinine ratio is a useful predictor of hypertension among Japanese community-dwelling persons. Clinical Hypertension. 31(1). e9–e9. 1 indexed citations
3.
Kawamoto, Ryuichi, et al.. (2025). Ambiguous motivations in medical school applicants: a retrospective study from Japan. Medical Education Online. 30(1). 2467487–2467487.
4.
Ito, Takanori, Yasuto Takeuchi, Kazuyuki Mizuno, et al.. (2024). Diagnostic guide for immune checkpoint inhibitor‐induced liver injury. Hepatology Research. 54(8). 719–726. 5 indexed citations
5.
Miyake, Teruki, Shinya Furukawa, Bunzo Matsuura, et al.. (2024). Combined effect of histological findings and diabetes mellitus on liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease. Hepatology Research. 54(11). 1016–1026. 1 indexed citations
6.
Tanaka, Atsushi, Keiji Tsuji, Yasuyuki Komiyama, et al.. (2024). RECAM‐J 2023—Validation and development of the Japanese version of RECAM for the diagnosis of drug‐induced liver injury. Hepatology Research. 54(6). 503–512. 7 indexed citations
7.
Hirooka, Masashi, Yohei Koizumi, Yoshiko Nakamura, et al.. (2023). B-mode shear wave elastography can be an alternative method to vibration-controlled transient elastography according to a moderate-scale population study. Journal of Medical Ultrasonics. 50(4). 473–483. 2 indexed citations
8.
Ohira, Hiromasa, Atsushi Takahashi, Mikio Zeniya, et al.. (2022). Clinical practice guidelines for autoimmune hepatitis. Hepatology Research. 52(7). 571–585. 14 indexed citations
9.
Miyake, Teruki, Bunzo Matsuura, Shinya Furukawa, et al.. (2022). Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus. Journal of Diabetes Investigation. 13(7). 1245–1252. 12 indexed citations
10.
Hirooka, Masashi, Yohei Koizumi, Yoshiko Nakamura, et al.. (2022). Spleen stiffness in patients with chronic liver disease evaluated by 2‐D shear wave elastography with ultrasound multiparametric imaging. Hepatology Research. 53(2). 93–103. 6 indexed citations
11.
Miyake, Teruki, Shinya Furukawa, Bunzo Matsuura, et al.. (2022). Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis. Biomedicines. 10(10). 2540–2540. 10 indexed citations
12.
Tanaka, Takaaki, Masashi Hirooka, Yohei Koizumi, et al.. (2021). Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method. PLoS ONE. 16(2). e0246315–e0246315. 12 indexed citations
13.
Hirooka, Masashi, Takaaki Tanaka, Yohei Koizumi, et al.. (2021). Measurement of multiple spleen lengths is not necessary for non‐invasive prediction of high‐risk esophagogastric varices. Hepatology Research. 52(2). 187–198. 2 indexed citations
14.
Miyake, Teruki, Bunzo Matsuura, Shinya Furukawa, et al.. (2021). Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status. Journal of Diabetes Investigation. 12(10). 1890–1898. 3 indexed citations
15.
Hirooka, Masashi, Yohei Koizumi, Takao Watanabe, et al.. (2021). Validation of the FibroScan‐aspartate aminotransferase score by vibration‐controlled transient and B‐mode ultrasound elastography. Hepatology Research. 51(6). 652–661. 7 indexed citations
16.
Koizumi, Yohei, Masashi Hirooka, Takaaki Tanaka, et al.. (2021). Noninvasive ultrasound technique for assessment of liver fibrosis and cardiac function in Fontan-associated liver disease: diagnosis based on elastography and hepatic vein waveform type. Journal of Medical Ultrasonics. 48(2). 235–244. 5 indexed citations
17.
Hirooka, Masashi, Yohei Koizumi, Takaaki Tanaka, et al.. (2020). Efficacy of combining electric‐field and coronal‐plane imaging to obtain ultrasound–ultrasound fusion images in monopolar radiofrequency ablation for patients with liver cancer. Hepatology Research. 50(8). 985–995. 4 indexed citations
18.
Imai, Yusuke, Osamu Yoshida, Takao Watanabe, et al.. (2019). Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation. PLoS ONE. 14(2). e0212589–e0212589. 16 indexed citations
19.
20.
Koizumi, Mitsuhito, Hironao Nakayama, Takao Watanabe, et al.. (2017). Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma. PLoS ONE. 12(5). e0177343–e0177343. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoichi Hiasa Breakdown of academic impact, for papers by Mario Pirisi Breakdown of academic impact, for papers by Parambir S. Dulai Breakdown of academic impact, for papers by Robert J. de Knegt Breakdown of academic impact, for papers by Stephen Ryder Breakdown of academic impact, for papers by Daniel Q. Huang Breakdown of academic impact, for papers by Qin Ning Breakdown of academic impact, for papers by Andrew S. Klein Breakdown of academic impact, for papers by Antonio Grieco Breakdown of academic impact, for papers by Davor Štimac
Rankless by CCL
2026